Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III,multicenter, randomized,evaluator‐blinded,active‐controlled trial and a phase III,multicenter, open trial |
| Affiliation: | 1. Department of Nutritional Science, Morioka University, Iwate, Japan;2. Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Iwate, Japan;3. Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan;4. Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan;5. Department of Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;6. Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan;7. Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan;8. Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan;9. Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan;10. Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Shizuoka, Japan;11. Department of Internal Medicine, Kagawa Prefectural Central Hospital, Takamatsu, Japan;12. Clinical Development Department, ASKA Pharmaceutical Co., Ltd, Tokyo, Japan;13. Shunan Memorial Hospital/Yamaguchi University, Yamaguchi, Japan |
